Suppliers / Asymchem Life Science Tianjin

Asymchem Life Science Tianjin

China Updated 9 July 2026

Asymchem Life Science Tianjin is an API manufacturer based in China. It holds 2 active US drug master files across a filed portfolio of 3 molecules. Its GMP standing is certified by US FDA. Its most recent recorded inspection, by US FDA, closed on 21 March 2025 as VAI.

2
active US DMFs
0
valid CEPs
1
registered plants 1 with an FDA FEI number
0
filings across 0 regulators
These figures were checked against the regulators' own files on 25 July 2026
Plants
1 of 1 confirmed
Inspections
4 of 4 confirmed
Sources: FDA Establishment Registration, read 4 May 2026. FDA drug inspection classifications, read 4 May 2026.

Inspection history

  • 21 March 2025 VAI US FDA
  • 26 July 2018 NAI US FDA
  • 22 May 2014 NAI US FDA
  • 18 May 2011 VAI US FDA

NAI means no action indicated, VAI means voluntary action indicated, and OAI means official action indicated.

Registered plants

Site FDA FEI
China, China 3007060980

What they file, and where

Molecule Regulators Docs
Dexmedetomidine SFDA (Saudi Arabia) 1
Liraglutide US FDA 1
Semaglutide US FDA 1

Also appears on these molecule pages

Dexmedetomidine API Liraglutide API Semaglutide API

Filings and GMP by regulator

Regulator Filings GMP certificates
US FDA None 1

Questions about Asymchem Life Science Tianjin

Does Asymchem Life Science Tianjin hold a US DMF or a CEP?
Asymchem Life Science Tianjin holds 2 active US drug master files. A drug master file is a submission to the FDA describing how an ingredient is made; a CEP is the EDQM's certificate that the substance meets its European Pharmacopoeia monograph. Both are filings rather than approvals.
Is Asymchem Life Science Tianjin FDA-registered?
One site operated by Asymchem Life Science Tianjin carries an FDA establishment identifier (FEI), which means it is registered with the FDA as a drug establishment. Registration is not the same as approval or inspection clearance.
How did Asymchem Life Science Tianjin's last inspection go?
The most recent inspection on record closed on 21 March 2025 as VAI (Voluntary Action Indicated: issues were found but did not warrant regulatory action). 4 inspections are on file.
Where does Asymchem Life Science Tianjin manufacture?
1 registered site is on record, in China (China). Every site is listed on this page with the register it came from.
What does Asymchem Life Science Tianjin make?
3 molecules are on record against Asymchem Life Science Tianjin, including Dexmedetomidine, Liraglutide and Semaglutide. Each links through to that molecule's full manufacturer list.
Which regulators recognise Asymchem Life Science Tianjin's GMP?
Current GMP certificates are on record from US FDA. GMP recognition covers the manufacturing site, separately from any filing on the substance itself.

Answered from this company's own record. Where a register holds nothing, the question is not asked rather than answered with a zero. How we count our figures.

Comparing suppliers?

Choose your molecules and target markets. Asymchem Life Science Tianjin comes back tiered against every other supplier able to file there.

Start for free
No sales call.

Open risk flags

  • The most recent inspection outcome was VAI, on 21 March 2025.

Comparable suppliers

Dr Reddy's Laboratories shares 1 molecule Maithri Drugs shares 1 molecule Biocon shares 1 molecule Piramal Pharma shares 1 molecule Moehs shares 1 molecule

Ranked by shared active ingredients where we have them, otherwise by country and comparable credentials.

Sources on this page

FDA
Drug master files, establishment registration, inspection classifications
EDQM
Certificates of suitability
EudraGMDP and national regulators
GMP certificates